Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 8.83% is 953% above its 5-year average of 0.84%, near the high end of its 5-year range (-7.69%–10.96%).
39.11% above its 12-month average of 6.35%.
Reported quarterly EBITDA margin; no daily interpolation. Q4 FY2026 (2026-06-30): 8.55%.
EBITDA MARGIN
8.83%
EBITDA MARGIN AVG TTM
6.35%
EBITDA MARGIN AVG 3Y
1.56%
EBITDA MARGIN AVG 5Y
0.84%
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+39.11%
CURRENT VS 3Y AVG
+467.22%
CURRENT VS 5Y AVG
+952.98%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Innovage Holding Corp.
Market Cap
$1.22B
EBITDA Margin
8.83%
TTM Avg
6.35%
3Y Avg
1.56%
5Y Avg
0.84%
Market Cap
$1.21B
EBITDA Margin
14.64%
TTM Avg
21.61%
3Y Avg
-2.02%
5Y Avg
-22.43%
Market Cap
$1.22B
EBITDA Margin
-2.25%
TTM Avg
-29.69%
3Y Avg
-65.15%
5Y Avg
-190.58%
Market Cap
$1.15B
EBITDA Margin
-234.91%
TTM Avg
-168.66%
3Y Avg
-182.22%
5Y Avg
-232.17%
Market Cap
$1.15B
EBITDA Margin
21.67%
TTM Avg
19.38%
3Y Avg
14.20%
5Y Avg
2.75%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Innovage Holding Corp. (INNV) | $1.22B | 8.83% | 6.35% | 1.56% | 0.84% |
| MannKind Corporation (MNKD)vs › | $1.21B | 14.64% | 21.61% | -2.02% | -22.43% |
| Cronos Group Inc. (CRON)vs › | $1.22B | -2.25% | -29.69% | -65.15% | -190.58% |
| Omada Health (OMDA)vs › | $1.23B | -2.49% | -12.68% | -37.94% | -37.94% |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.24B | N/A | N/A | N/A | N/A |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.17B | N/A | N/A | N/A | N/A |
| Kardigan, Inc. (KARD)vs › | $1.27B | N/A | N/A | N/A | N/A |
| Nektar Therapeutics (NKTR)vs › | $1.15B | -234.91% | -168.66% | -182.22% | -232.17% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.15B | 21.67% | 19.38% | 14.20% | 2.75% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.14B | N/A | N/A | N/A | N/A |
Gross Margin
21.4%
EBITDA Margin
8.8%
Operating Margin
6.4%
Net Margin
-0.3%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 8.55% |
| 2026-03-31 | 10.96% |
| 2025-12-31 | 8.75% |
| 2025-09-30 | 5.66% |
| 2025-06-30 | -2.19% |
| 2025-03-31 | -2.19% |
| 2024-12-31 | -3.46% |
| 2024-09-30 | 0.25% |
| 2024-06-30 | 0.22% |
| 2024-03-31 | -0.38% |
| 2023-12-31 | 1.33% |
| 2023-09-30 | -3.53% |
| 2023-06-30 | -3.74% |
| 2023-03-31 | -2.42% |
| 2022-12-31 | -5.98% |
| 2022-09-30 | -7.69% |
| 2022-06-30 | -5.12% |
| 2022-03-31 | -1.59% |
| 2021-12-31 | 3.56% |
| 2021-09-30 | 8.64% |
| 2021-06-30 | 7.98% |
| 2021-03-31 | -1.31% |
| 2020-12-31 | 14.96% |
| 2020-09-30 | -23.09% |
| 2020-06-30 | 15.18% |
| 2020-03-31 | 10.87% |
